Randox Discovery by Randox Laboratories Ltd.

The Discovery is an exciting and disruptive analyser capable of molecular and immunoassay testing

• Simultaneous detection of hundreds of targets from a single patient sample via patented biochip technology
• Flexible test menu comprising immunoassay and genetic tests for infectious diseases & oncology
• Rapid turnaround time. Three hours to first batch of results with results for subsequent batches every hour after
• Fully automated platform increasing operator walkaway time.  A single operator is all that’s required to run up to 3 Discovery analysers
• Simple and easy to use. Intuitive user interface guides the operator through the entire testing process

Randox Discovery is comprised of three interconnected modules which each  operate independently performing different aspects of the diagnostic testing process. Each module is separated by a physical barrier to prevent contamination and is accessible via a door. The workflow process runs from right to left and is compatible with lean working principles.

Nucleic Acid Extraction

Module I is responsible for DNA/RNA extraction. After extraction the sample is automatically transferred to Module II. Before transfer, Module I detects the presence of Module II cartridges using a unique vision system. 

Multiplex PCR

Module II is responsible for amplification of the extracted nucleic acid by End-Point PCR. UV light is used to sterilise the module and reduce the risk of crossover contamination.

Biochip Hybridisation & Detection

Module III is used in both immunoassay & molecular workflows and is responsible for hybridisation and subsequent detection using patented biochip technology. The detection camera uniquely moves between sample cartridges to detect biochip chemiluminescence.